True or false: Registrants of the Drug Enforcement Administration must distribute a substance as requested, even if it is suspicious.

The statement is false because registrants of the Drug Enforcement Administration (DEA) are not obliged to distribute a substance if they find the request suspicious. It is essential for registrants, who include healthcare professionals and pharmacies, to ensure that all transactions comply with legal and ethical standards, particularly when it comes to controlled substances.

If a registrant notices suspicious orders, they have a responsibility to investigate further, document their findings, and potentially report the situation to the DEA. This is crucial in preventing the diversion of controlled substances for illicit use. Registrants must use their professional judgment to determine the legitimacy of each order based on factors like the ordering pattern, quantity requested, and the patient's medical history.

In this context, merely following through on every request without due diligence could lead to significant legal consequences and ethical breaches, making it imperative that registrants maintain vigilance in recognizing and addressing any signs of suspicious activity.